TY - JOUR
T1 - Long-term survival in visceral transplant recipients in the new era
T2 - A single-center experience
AU - Elsabbagh, Ahmed M.
AU - Hawksworth, Jason
AU - Khan, Khalid M.
AU - Kaufman, Stuart S.
AU - Yazigi, Nada A.
AU - Kroemer, Alexander
AU - Smith, Coleman
AU - Fishbein, Thomas M.
AU - Matsumoto, Cal S.
N1 - Publisher Copyright:
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2019/7
Y1 - 2019/7
N2 - There is a paucity of data on long-term outcomes following visceral transplantation in the contemporary era. This is a single-center retrospective analysis of all visceral allograft recipients who underwent transplant between November 2003 and December 2013 with at least 3-year follow-up data. Clinical data from a prospectively maintained database were used to assess outcomes including patient and graft survival. Of 174 recipients, 90 were adults and 84 were pediatric patients. Types of visceral transplants were isolated intestinal transplant (56.3%), combined liver-intestinal transplant (25.3%), multivisceral transplant (16.1%), and modified multivisceral transplant (2.3%). Three-, 5-, and 10-year overall patient survival was 69.5%, 66%, and 63%, respectively, while 3-, 5-, and 10-year overall graft survival was 67%, 62%, and 61%, respectively. In multivariable analysis, significant predictors of survival included pediatric recipient (P =.001), donor/recipient weight ratio <0.9 (P =.008), no episodes of severe acute rejection (P =.021), cold ischemia time <8 hours (P =.014), and shorter hospital stay (P =.0001). In conclusion, visceral transplantation remains a good option for treatment of end-stage intestinal failure with parenteral nutritional complications. Proper graft selection, shorter cold ischemia time, and improvement of immunosuppression regimens could significantly improve the long-term survival.
AB - There is a paucity of data on long-term outcomes following visceral transplantation in the contemporary era. This is a single-center retrospective analysis of all visceral allograft recipients who underwent transplant between November 2003 and December 2013 with at least 3-year follow-up data. Clinical data from a prospectively maintained database were used to assess outcomes including patient and graft survival. Of 174 recipients, 90 were adults and 84 were pediatric patients. Types of visceral transplants were isolated intestinal transplant (56.3%), combined liver-intestinal transplant (25.3%), multivisceral transplant (16.1%), and modified multivisceral transplant (2.3%). Three-, 5-, and 10-year overall patient survival was 69.5%, 66%, and 63%, respectively, while 3-, 5-, and 10-year overall graft survival was 67%, 62%, and 61%, respectively. In multivariable analysis, significant predictors of survival included pediatric recipient (P =.001), donor/recipient weight ratio <0.9 (P =.008), no episodes of severe acute rejection (P =.021), cold ischemia time <8 hours (P =.014), and shorter hospital stay (P =.0001). In conclusion, visceral transplantation remains a good option for treatment of end-stage intestinal failure with parenteral nutritional complications. Proper graft selection, shorter cold ischemia time, and improvement of immunosuppression regimens could significantly improve the long-term survival.
KW - clinical research/practice
KW - health services and outcomes research
KW - immunosuppressive regimens - induction
KW - intestinal (allograft) function/dysfunction
KW - intestine/multivisceral transplantation
UR - http://www.scopus.com/inward/record.url?scp=85063437718&partnerID=8YFLogxK
U2 - 10.1111/ajt.15269
DO - 10.1111/ajt.15269
M3 - Article
C2 - 30672105
AN - SCOPUS:85063437718
SN - 1600-6135
VL - 19
SP - 2077
EP - 2091
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 7
ER -